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A B S T R A C T
Immunosuppression is a well-established risk factor for Visceral Leishmaniasis. Post-immunosuppression leish-
maniasis is characterized by an increase of parasite burden, hematopoietic disorders and unusual clinical
manifestations. Although there are many reports on bone marrow ﬁndings in VL, less is known about the re-
lationship between parasite dynamics in this organ and the function of either hematopoietic stem cells and
progenitor cells themselves. In the present study, we tackle these issues using a new approach of infecting human
stem cells derived from bone marrow with L. infantum. Using this strategy, we show that human hematopoietic
stem cells (hHSC) are able to phagocytize L. infantum promastigotes and release modulatory and pro-in-
ﬂammatory cytokines, mainly TNF-α. Our results demonstrated that L. infantum infection in vitro enhances
hematopoiesis, favoring the development of erythrocitic lineage through a mechanism yet unknown. Moreover,
we found that L. infantum infection alters the phenotypic proﬁle of the hematopoietic progeny; modifying the
surface markers expression of diﬀerentiated cells. Thus, our study represents a rare opportunity to monitor the in
vitro diﬀerentiation of human stem cells experimentally infected by L. infantum to better understand the con-
sequences of the infection on phenotypic and functional proﬁle of the cell progeny.
1. Introduction
Leishmaniasis is a group of diseases caused by kinetoplastids be-
longing to the genus Leishmania, which are transmitted by sandﬂy bites
during a blood meal. Leishmania sp. causes a wide spectrum of human
diseases, ranging from being asymptomatic to lethal visceral leishma-
niasis [2,21]. Whereas most immunocompetent individuals will not
develop disease after Leishmania infection, immunosuppression is a
well-established risk factor for disease. Although immunosuppression
has historically been mainly observed in human immunodeﬁciency
virus (HIV-infected patients), non-HIV related immunosuppressive
conditions are becoming more common, mainly because of the ther-
apeutic use of immunosuppressive drugs [27]. Some previous research
has been attracting attention for documenting atypical clinical mani-
festations in individuals diagnosed with leishmaniasis, after use of im-
munosuppressive drugs [8,11,12]. Clinical presentation in im-
munosuppressed individuals is characterized by an increase in parasite
burden, hematopoietic disorders and atypical clinical manifestations,
which are usually misdiagnosed or accepted as a ﬂare-up of an un-
related underlying condition. The absence of clinical signals or symp-
toms before immunosuppression suggests that Leishmania parasites are
using sites of immunological privilege, such as bone marrow cells, for
maintenance and multiplication without disease manifestation under
normal immunological conditions [11]. Furthermore, the presence of
Leishmania donovani amastigotes inside bone marrow hematopoietic
stem cells and stromal macrophages has been reported after
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experimental infection of Balb/c mice by Cotterell et al. [7].
Few studies have addressed the immunological consequences of
bone marrow infection by visceral Leishmania spp. Leishmania-infected
stromal cells display a modiﬁed capacity to recruit and support hema-
topoietic progenitor diﬀerentiation into regulatory DCs. Moreover,
aberrant expression of CCL8 by diseased stromal tissue may be involved
in the switch from resolving to persistent infection [18]. Besides, it has
been reported that L. donovani infection of stromal macrophages en-
hances myelopoiesis trough a mechanism involving GM-CSF and TNF-α
[7].
Thus, to better understand the particularities that are involved in
this type of infection, we infect stem cells derived from human bone
marrow with L. infantum promastigotes. Using this strategy, we show
that human hematopoietic stem cells are able to phagocytize L. infantum
promastigotes and release pro-inﬂammatory and modulatory cytokines
early after infection. Moreover, our results indicated that infection by L.
infantum promotes an increase of red and white colonies after in vitro
hematopoiesis assay through a yet unknown mechanism. Thus, our
study represents a rare opportunity to monitor the in vitro diﬀerentia-
tion of human stem cells infected by L. infantum and understand the
impact on the phenotypic and functional immune proﬁle of their pro-
geny (Table 1).
2. Samples, material and methods
2.1. Samples
Human hematopoietic stem cells (hHSC) used in this study were
obtained from Hematological Clinic, Belo Horizonte, Brazil. All donors
who agreed to collaborate with this study signed an informed written
consent form. These patients were carriers of hematological diseases
that do not compromise the medullary compartment. All donors were
monitored by a hematologist to ensure the eligibility of samples. The
HSCs were collected by leukapheresis after the use of the drug G-CSF by
the donors, which stimulate the proliferation and mobilization of these
cells to the peripheral blood. After collection, these cells were cryo-
preserved at −80 °C, using a commercial solution of hydroxyethyl
starch solution 60% (HES), albumin 40% and dymethilsulfoxide 10%
(DMSO). All the donors, carriers of hematological diseases, were suc-
cessfully transplanted with autologous cells and cured after the process,
guaranteeing the quality of the collected samples. The cells used in the
present study are those that would be discarded by the clinic because of
loss of shelf life for use in human medical procedures. The use of this
type of biological material has been validated by the Agência Nacional
de Vigilância Sanitária (National Sanitary Surveillance Agency of Brazil -
ANVISA). All the experiments were performed using representative
samples of healthy and baseline diseases donors. This work complied
with resolution number 466/2012 from the National Health Council for
research involving human subjects and was approved by the Ethical
Committee at Instituto René Rachou (CEPSH/IRR/FIOCRUZ protocol
1.368.058), Belo Horizonte, Minas Gerais, Brazil.
2.2. Viability of hematopoietic stem cells (hHSC)
The viability of all samples was evaluated using Trypan Blue la-
beling. Live and dead cells were counted using an automated cell
counter (Countess™ - Thermo Scientiﬁc) to assess viability percentage.
The ideal viability for the use of cells had to be equal to or higher to
85%.
2.3. Alexa Fluor 647-labeling procedure for L. Infantum
Promastigote forms of L. infantum – PP75 strain – were cultivated in
Schneider’s Drosophila Medium (Thermo Fischer™) supplemented with
20% of fetal bovine serum (FBS – Sigma Aldrich™) and NNN (Novy,
MacNeal, Nicolle) medium for 8 days at 25 °C in a B.O.D incubator. Live
and ﬁxed parasites were stained with Alexa Fluor 647 (AF647 - NHS
Ester – Thermo Fischer™) at a ﬁnal concentration of 3.2 µg/mL at 37 °C
for 30 min in a 5% CO2 humidiﬁed incubator. After the labeling pro-
cedure, parasites were washed three times with PBS 1x and re-sus-
pended in PBS 1x supplemented with 10% FBS. The AF647-labeled
parasite suspension was adjusted to 1×108/mL, and maintained at
25 °C in a B.O.D. incubator until use. For the ﬁxed L. infantum condition,
after the third wash step, parasites were re-suspended in FACS ﬁx so-
lution 10.0 g/L of paraformaldehyde, 1% sodium cacodylate, 6.63 g/L
of sodium chloride and 0.01% of sodium azide -Sigma Chemical- pH
7.2) and stored at 4 °C until use as described by Vitelli-Avelar et al.
[28]. Aliquots of AF647-labeled parasites were then run through a ﬂow
cytometer to evaluate the eﬃciency of the AF647 staining procedure.
Ideal AF647-labeled parasite staining would lead to a single peak
around 102 and 103 log intervals in FL4/AF647 histogram plots. Ad-
ditionally, the live-labeled parasites were monitored by optical micro-
scopy to assess motility and, via Trypan blue staining, viability quality
control.
2.4. Short-term in vitro phagocytosis protocol with AF647-labeled live and
ﬁxed L. Infantum
To perform the culture of hHSC, the number of cells was adjusted to
1x107 cells/mL using RPMI- 1640 (GIBCO™) supplemented with 0.5%
of sodium heparin. Short-term in vitro cultures were performed using
14mL polypropylene tubes (Falcon™; BD Pharmingen, San Jose, CA,
USA) in three distinct platforms referred to as “Unstimulated (CT)”,
“Live L. infantum-Stimulated (Leish-L)” and “Fixed L. infantum-
Stimulated (Leish-F)” cultures. For “CT” cultures aliquots of 1mL hHSC
suspension were incubated with 1mL of RPMI- 1640. For the Leish-L
cultures, aliquots of 1mL of hHSC suspension were incubated with
500 µL of RPMI-1640 and 500 µL of AF647-labeled live L. infantum
organisms at 1× 108 parasites/mL. For the Leish-F cultures aliquots of
1mL of hHSC suspension were incubated with 500 µL of RPMI-1640
and 500 µL of AF647-labeled ﬁxed L. infantum organisms at 1× 108
parasites/mL.
Both, unstimulated and stimulated cultures were performed in du-
plicate. The tubes were incubated under gentle shaking by an orbital
shaker for 120min at 37 °C in a 5% CO2 humidiﬁed incubator.
Following the incubation, the cultures were treated with EDTA
(Ethylenediamine tetraacetic acid - SIGMA™) at 20mM, and maintained
at room temperature for 15min prior to immunophenotypic staining for
cell surface markers.
Table 1
Samples donnors.
ID Sex Age Diagnosis % CD34 LGC/mm3
RCPP M 55 MM 0.20 313,750
WBJ M 51 MM 0.19 318,750
VAS F 52 MM 0.17 297,500
RFS M 46 MM 0.27 314,500
AJS M 40 MM 7.23 242,500
NJP F 45 MM 0.45 278,400
JMC M 48 H 0.56 280,200
DNPS F 42 H 0.22 256,300
RAF M 55 MM 0.22 260,000
JFFA F 50 HL 2.09 278,250
MCCO F 66 MM 0.18 162,500
MALM F 73 MM 0.45 232,500
OGA M 0.70 303,250
ACGS M 61 MM 1.06 232,250
M- Male, F- Female, MM- Multiple Myeloma, H- Healthy, HL- Hodgkin's lymphoma, GC-
Leukocyte's global concentration
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2.5. Analysis of cell surface markers and intracytoplasmic cytokines
For cell surface marker analysis, aliquots of 200 µL of cell cultures
obtained from the phagocytosis assay were incubated for 30min at
room temperature with (PerCP)-labeled anti-CD34 mAb (clone 8G12),
(FITC)-labeled anti-CD45 mAb (clone 2D1), (FITC)-labeled anti-CD33
(clone HIM3-4), (PE)-labeled anti-CD13 (clone WM15), (FITC)-labeled
anti-HLA-DR mAb (clone G46-6), (PE)-labeled anti-CD14 mAb (clone
M5E2), (PE)-labeled anti-CD41a mAb (clone HIP8), (FITC)-labeled anti-
CD235a mAb (clone GA-R2) and (FITC)-labeled anti-CD19 mAb (clone
HIB19), all purchased from Becton Dickinson-BD™. Following incuba-
tion, the red blood cells were lysed with FACS lysing solution (BD
Biosciences™), except the samples labeled with FITC-anti-CD235a,
which identiﬁes erythrocyte lineage. The samples were washed with
FACS buﬀer (PBS 0.5% of bovine serum albumin and 0.1% sodium
azide - BD Biosciences™), and ﬁxed with FACS ﬁx solution. A total of
50,000 events were acquired in a FACScalibur ﬂow cytometer (Becton
Dickinson and Company™), and analyses of the immunophenotypic and
morphometric parameters were determined using FlowJo™ version
10.07.
For intracytoplasmic cytokine analysis, aliquots of 500 µL of cell
cultures were incubated for 30min at room temperature with PerCP-
labeled anti-CD34 and FITC-labeled anti-CD45 mAbs to identify hHSC
subsets. Following incubation, the red blood cells were lysed with FACS
lysing solution and the samples were kept with FACS permeabilizing
solution. Following incubation, the samples were centrifuged at 600×g
for 7min at room temperature and the cell pellet washed with FACS
buﬀer. After centrifugation, the cells were resuspended with FACS
buﬀer. Cells were then stained with anti-cytokine mAbs including PE-
labeled anti-IFN-γ (clone B27), anti-IL-10 (clone JES3-19F1) anti-IL-4
(clone 8D4-8), anti-TNF-α (clone MAb11) by incubation for 30min at
room temperature in the dark. After incubation, the cells were washed
twice and ﬁxed with FACS ﬁx solution. A total of 50,000 events were
acquired in a FACScalibur ﬂow cytometer and morphometric, pheno-
typic and functional parameters were determined using FlowJo™ ver-
sion 10.7.
2.6. In vitro hematopoiesis assay
A total of 5×106 cells in the presence (Leish-F and Leish-L) or
absence (CT) of L. infantum stimuli was placed in six-well plates with
MethoCult H4034 (Stem Cell™), a speciﬁc medium containing all
growth factors necessary to perform hematopoiesis in vitro. The cell
suspension was incubated for fourteen days at 37 °C in a CO2 incubator.
At the endpoint of the cultures, the colonies formed were counted and
photographed using an inverted microscope coupled to a camera (Axio
Vert.A1 microscope, ZeissTM). For phenotypic analysis by ﬂow cyto-
metry, the colonies, both red and white, were recovered from the six-
well plates, removed from culture medium and washed with FACS
buﬀer. For cell surface marker analysis, the cell suspensions were in-
cubated for 30min at room temperature with PerCP-labeled anti-CD34
mAb and (FITC)-labeled anti-CD45 mAb, (FITC)-labeled anti-CD33,
(PE)-labeled anti-CD13, (FITC)-labeled anti-HLA-DR mAb, (PE)-labeled
anti-CD14 mAb, CD41a mAb, (FITC)-labeled anti-CD235a mAb and
(FITC)-labeled anti-CD19 mAb, all purchased from Becton Dickinson-
BD™. The samples were washed with FACS buﬀer, and ﬁxed with FACS
FIX solution. A total of 50,000 events were acquired in a FACScalibur
ﬂow cytometer, and analyses of the immunophenotypic and morpho-
metric parameters were determined using FlowJo™ software (version
10.07).
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Fig. 1. (A) Strategy of the analysis used to select CD34+ and CD45+ cells and evaluate FL-4+L infantum phagocytosis percentage. (B) Strategy of selection of subpopulations of CD45+
cells (lymphocytes, monocytes and granulocytes) and evaluate FL-4+L. infantum phagocytosis percentage. The capacity of (C) hHSC, (D) monocytes and (E) granulocytes to phagocytize
live (Leish-V) or ﬁxed (Leish-F) FL-4+L infantum promastigotes. (F) Index of the percentage of monocytes/granulocytes that phagocytized live (Leish-V) or ﬁxed (Leish-F) FL-4+L infantum
promastigotes. Results are expressed as mean percentage ± standard error (SE) of Cells-FL-4+. Signiﬁcance was considered at p≤ 0.05 and highlighted by lines between the three
distinct groups.
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3. Results
3.1. Bone marrow-derived hHSC, monocytes and granulocytes are able to
phagocytize L. Infantum promastigotes
We started to evaluate the capacity of bone marrow-derived hHSC,
monocytes and granulocytes to phagocytize live or ﬁxed L. infantum
promastigotes. Upon two hours of interaction, we observed that hHSCs
phagocyted a high percentage of both live as well as ﬁxed L. infantum
when compared with the CT group (Fig. 1C). Similarly, we observed a
high percentage of monocytes and granulocytes that internalized ﬁxed
(Leish-F) and live (Leish-L) L. infantum promastigotes in comparison to
the CT group (Fig. 1D and E). Aiming to compare the phagocytic ca-
pacity between monocytes and granulocytes, we calculated an index of
the percentage of monocytes FL-4+ divided by granulocytes FL-4+ and
found that about 1.5 times more monocytes phagocytized live or ﬁxed
L. infantum than granulocytes (Fig. 1F).
3.2. Bone marrow-derived hHSC, lymphocytes, monocytes and granulocytes
produce high levels of modulatory and pro-inﬂammatory cytokines,
especially TNF-α, after L. Infantum internalization
Aiming to evaluate the functional proﬁle of hHSC, lymphocytes,
monocytes and granulocytes derived from bone marrow, we analyzed
the intracytoplasmic expression of IL-4, IL-10, IFN-γ and TNF-α, after
stimulation with ﬁxed or live L. infantum. The expression of these cy-
tokines are crucial for disease evolution, the balance between pro-in-
ﬂammatory and modulatory is related to a good prognosis. Data ana-
lysis demonstrated an increased frequency of hHSC IL-4+ when we
compared Leish-L or Leish-F with non-infected cultures (Fig. 2C); the
same signiﬁcant increase of granulocytes, lymphocytes and monocytes
IL-4+ was observed comparing Leish-L with Leish-F or CT group
(Fig. 3C). Evaluating another modulatory cytokine expression, we
observed a high percentage of hHSC IL-10+ when we compared Leish-L
with Leish-F with the CT group (Fig. 2D). Moreover, we found a sig-
niﬁcant increase in the percentage of lymphocytes, monocytes and
granulocytes IL-10+ comparing Leish-L and Leish-L with the CT group
(Fig. 3D). Analysis of pro-inﬂammatory cytokine production demon-
strated a high percentage of hHSC IFN-γ+ when we compared Leish-L
and Leish-F with the CT group (Fig. 2E). The same pattern occurs when
we analyze IFN-γ+ production by lymphocytes, monocytes and granu-
locytes derived from bone marrow (Fig. 3E). Finally, we evaluated TNF-
α production and observed a great increase in the percentage of hHSC
TNF-α producers when comparing Leish-L with Leish-F with the CT
group (Fig. 2F). We also observe the same increase evaluating TNF-α
production by lymphocytes and granulocytes, but in monocytes we only
observed this increase when comparing Leish-L and Leish-F with the CT
group (Fig. 3F). Interestingly, we observed signiﬁcant diﬀerences in the
production of most cytokines between the Leish-L and Leish-F groups.
This found is very important because it shows that the live parasites are
more prone to modify the immunologic environment trough cytokines
release.
3.3. The infection of hHSC by L. Infantum increases in vitro hematopoiesis,
favoring erythroid colony formation
Aiming to evaluate the impact of L. infantum infection on hemato-
poiesis proﬁle, we performed an in vitro hematopoiesis assay, after a
short-term hHSC/Leishmania interaction, until 14 days of diﬀerentia-
tion. At the end point of the cell diﬀerentiation period, we photo-
graphed the wells and counted the colonies formed (Fig. 4A–D). A
higher number of total colonies were formed when previously stimu-
lated with L. infantum (Leish) parasites, compared to the unstimulated
cultures (CT) (Fig. 4E). Evaluating separately the white and red co-
lonies, we observed an increased number of red colonies in Leish group
in comparison with the CT group. The same increase occurs comparing
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Fig. 2. (A) Strategy of the analysis used to select CD34+ and CD45+ cells and (B) evaluation of the TNF-α+ hHSC percentage. (C-F) Analysis of intracellular cytokine expression by bone
marrow derived hHSC in the absence (Cel) or presence of live (Leish-L) or ﬁxed (Leish-F) L. infantum promastigote stimuli: (C) IL-4 (D) IL-10 (E) IFN-γ and (F) TNF-α. Results are
expressed as mean percentage ± standard error (SE) of hHSC+Cytokine+. Signiﬁcance was considered at p≤ 0.05 and highlighted by lines between the three distinct groups.
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red colonies in Leish group with white colonies in CT group and white
colonies in Leish group (Fig. 4F), concluding that L. infantum stimulates
erythropoiesis.
3.4. L. Infantum infection induces a diﬀerent pattern of cell diﬀerentiation
during hematopoiesis aﬀecting surface marker expression after in vitro
hematopoiesis
After ensuring the capacity of hHSC to phagocytize L. infantum
promastigotes, and the ability to respond to infection through an al-
tered cytokine production and hematopoietic pattern, we compared the
possible diﬀerences in phenotypic cell proﬁle after L. infantum infec-
tion. To assess this data, we evaluated surface marker expression at two
diﬀerent time points of infection, at 2 h (T0) and at 14 days (T14), the
ﬁnal point of hematopoiesis. Thus, when we evaluated the subpopula-
tions of CD45+ cells we observed an increase in the percentage of
lymphocytes and granulocytes comparing Leish-L group at T14 with
Leish-L group at T0 (Fig. 5B and D). In contrast, we had a diminished
percentage of lymphocytes in the CT group compared to the same group
after in vitro hematopoiesis (Fig. 5B). Evaluating the percentage of
CD45+ monocytes, we found a decrease when comparing the CT group
with Leish-L at T0 (Fig. 5C). Moreover, when we evaluated cells of the
granulocytic lineage, CD33+, and erythrocytic lineage, CD235a+, we
observed an increase in the percentage of these cells comparing Leish-L,
Leish-F and CT groups after 14 days of culture with the same groups at
time T0 (Fig. 5H and K). Besides this, evaluating markers of the
monocytic lineages CD14+ and HLA-DR we observed a signiﬁcant in-
crease of HLA-DR MFI in Leish-L group at T0 compared with the CT
group and higher percentage of CD14+ cells comparing Leish-L at T14
with Leish-F at the same point in time and CT at T0 (Fig. 5E and F).
When we analyzed CD19+ cells, a marker of lymphocytic lineage, we
found an increase of these cells in Leish-L and CT groups at T14 com-
pared with the respective groups at T0 (Fig. 5I). Our data demonstrated
no statistical diﬀerences when we evaluated CD13+ cells and CD41a+
cells in all groups at both time points (Fig. 5G and J). Thus, through
these data we observed that the infection of hHSC by L. infantum in
addition to alter the functional proﬁle of infected cells is also capable to
increase in vitro hematopoiesis and modify the phenotypic proﬁle of
their progenies.
4. Discussion
Immunocompromised VL patients exhibit non-typical clinical man-
ifestations that could be diﬃcult to diagnose fast and accurately,
leading eventually to patient decease. The absence of positive results in
some clinical tests, confusing clinical signs and hematopoietic altera-
tions are the main features of Leishmaniasis after immunossupression.
Some studies, mainly case reports, have found Leishmania spp. in sites
such as vitreous humour, spleen and bone marrow. These ﬁndings show
that these parasites seek sites of immunological privilege for their
maintenance and multiplication, being the immune system unabled to
clear them.
Using murine models, Cotterell et al. [7] had previously demon-
strated the capacity of L. donovani to infect bone marrow and spleen
cells. Additionally, Allahverdiyev et al. [3] found that adipose tissue-
derived mesenchymal stem cells serve as a host in latent Leishmania
infection. In the present study, we had a rare opportunity to evaluate
the capacity of L. infantum to infect hematopoietic stem cells and to
observe the impact of this infection during the process of hematopoiesis
in vitro using human samples provided by leukapheresis.
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Fig. 3. (A) Strategy of the analysis used to select subpopulations of CD45+ cells (lymphocytes, monocytes and granulocytes) and (B) evaluation of the percentage of TNF-α+ monocytes.
(C-F) Analysis of intracellular cytokine expression by subpopulations of CD45+ cells, lymphocytes, monocytes and granulocytes in the absence (CT) or presence of live (Leish-L) or ﬁxed
(Leish-F) L. infantum promastigote stimuli: IL-4 (D) IL-10 (E) IFN-γ and (F) TNF-α. Results are expressed as mean percentage ± standard error (SE) of Cytokine+Cell. Signiﬁcance was
considered at p≤ 0.05 and highlighted by lines between the three distinct groups.
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We showed that human hematopoietic stem cells, monocytes and
granulocytes can be infected in vitro with L. infantum. The fact that L.
infantum is able to infect hematopoietic stem cells derived from bone
marrow seems to be advantageous for the maintenance of asympto-
matic infection, since bone marrow is one of the immunologically pri-
vileged sites of the human body. It has been widely reported that one
mechanism employed by Leishmania to evade the immune system and
remain alive in an infected cell is the blockage or delay of diﬀerent
apoptosis pathways, such as the mitochondrial apoptotic pathway and
death triggered by extracellular ATP [1,10]. Thus, the process of pha-
gocytosis and the mechanisms triggered by the parasite that guarantee
the survival of the parasitized cell are events of great importance that
may favor the maintenance of the infection. Studies in murine models
point stromal macrophages as the main host cells in chronic LV [7].
This hypothesis is reinforced by the low rate of infection of hemato-
poietic stem cells in infected animals, suggesting stromal cells as site of
replication and maintenance of amastigotes [7,16]. In contrast with
these results, we found a high frequency of hematopoietic stem cells
that phagocytized L. infantum promastigotes. We also observed a high
percentage of monocytes and granulocytes that phagocytized L. in-
fantum. After the internalization of the parasite, we also observed,
through the expression of HLA-DR, the activation of monocytes,
showing the ability of these cells to respond to the stimuli caused by the
presence of Leishmania. Besides the increased frequency of infection,
hHSC and subpopulations of CD45+ cells were able to produce cyto-
kines in response to parasite presence. We observed a great percentage
of cells producing important cytokines involved in VL infection, such as
IL-10, IL-4, IFN-γ and TNF-α.
The balance between modulatory and pro-inﬂammatory cytokines
has been identiﬁed as a key in the control and healing of VL. We have
recently seen that the role played by some cytokines is extremely de-
pendent on the context and microenvironment in which they act. IL-4,
for example, has already been related only to anti-inﬂammatory events,
but now it is known that this cytokine participates in synergy with IFN-
γ in the intracellular NO production pathway, an important leishma-
nicidal mechanism [17,20,29]. Interestingly, although NO can kill in-
tracellular parasites, this molecule can play a dual role, being involved
in T cells immunosuppression and apoptosis [5,23]. In our results we
not only observed a high percentage of hHSC and CD45+ cells produ-
cing IL-4, but also a lower percentage of lymphocytes after hemato-
poiesis of L. infantum infected cells. This could represent an important
mechanism of regulation because although NO can causes the in-
tracellular death of Leishmania, the same molecule decreases the ac-
tivity of T lymphocytes, promoting the maintenance of the infection.
Schmid and collaborators [24] associated T lymphocyte modulation
during L. major infection to MDSCs (Myeloid-derived Suppressor Cells).
These cells are derived from myeloid precursors but have been pre-
vented from fully diﬀerentiating into mature cells [31]. This cell phe-
notype was not evaluated in our study, but could be related to some of
our ﬁndings. MDSCs can be activated and expanded through the sti-
mulation of Toll-like receptors and cytokines such as IFN-γ and IL-4,
which can trigger pathways such as STAT6, STAT1 and NF-kB [9].
These cells are also able to phagocytize Leishmania, produce ROS and
NO and increase the secretion of IL-10, an important modulatory cy-
tokine, in the context of VL [24]. Interesting, we observed an increased
percentage of hHSC and IL-10+ CD45+ producer cells, especially
granulocytes. Modulation of anti-Leishmania immune response by
MDSCs could support the hypothesis of the maintenance of an asymp-
tomatic residual infection in bone marrow cells, with great potential for
reactivation in cases of immunosuppressed patients.
Alteration of hematopoiesis is one of most common clinical ﬁndings
in immunossuppressed patients with VL. Our results demonstrated that
the presence of L. infantum infected cells alters the hematopoietic pro-
ﬁle during hematopoiesis in vitro. We observed a greater number of cell
colonies in cultures stimulated with L. infantum promastigotes after
14 days. hHSC generally remain in a quiescent or dormant state but can
A B 
C D 
E 
F 
Fig. 4. Wells of stem cell cultures at the end point of in vitro hematopoiesis assay in the presence (A) or absence (B) of L. infantum. (C) White and (D) red colonies (50x) at the end point of
culture. (E) Count of total number of cell colonies after 14 days of cell diﬀerentiation in the absence (CT) or presence of live L. infantum promastigotes (Leish-L). (F) Count of red and white
cell colonies after 14 days of cell diﬀerentiation in the absence (CT) or presence of live L. infantum promastigotes (Leish-L). Results are expressed as mean ± standard error (SE) of
absolute number of colonies. Signiﬁcance was considered at p≤ 0.05 and highlighted by lines between the three distinct groups.
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Fig. 5. (A) Strategy of the analysis used to select po-
pulations of CD13+ and CD14+ cells and to analyze
HLA-DR+ cells by mean ﬂuorescence intensity (MFI).
The strategy of the analysis of lymphocytes, granu-
locytes and monocytes (B, C and D) was showed in
Fig. 1B. (B to K) Analysis of the phenotypic proﬁle of
bone marrow derived cells by expression of surface
markers of granulocytic, lymphocytic, monocytic, er-
ythrocitic and platelet lineages at two diﬀerent time
points – T0 and T14. Cell cultures were not stimulated
(CT) or stimulated with live (Leish-L) or ﬁxed (Leish-
F) L. infantum promastigotes. Results are expressed as
mean percentage ± standard error (SE) or MFI ±
standard error (SE) of each surface marker. Sig-
niﬁcance was considered at p≤ 0.05 and highlighted
by lines between the three distinct groups.
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be stimulated under conditions of stress. They are able to proliferate
and diﬀerentiate to replenish cellular progeny after cell death or
apoptosis [4]. Thus, the presence of Leishmania infected cells could
trigger events that could disrupt the hematopoietic balance, thus in-
creasing cell diﬀerentiation. According to this hypothesis, a study from
Cotterell et al. [7] found elevated levels of GM-CSF and TNF-αmRNA in
cell cultures in the presence of L. donovani amastigotes and the absence
of exogenous growth factors. The role of TNF-α has been extensively
investigated in the context of VL as a potent pro-inﬂammatory mole-
cule. This cytokine can also participate in the regulation of hemato-
poiesis, yet with a not well deﬁned role [6,15]. It is known that, ex-
perimentally, L. donovani induced-TNF-α acts in synergy with GM-CSF
to form CFU-GM, but TNF-α alone had no eﬀect on myelopoiesis [7].
Besides this, TNF-α produced by CD8+ bone marrow derived cells en-
hanced HSC clonogenicity, increased the proportion of multipotent
progenitors in vitro, and prevented HSC apoptosis in vitro and in vivo
[22]. In the present study, we did not quantify GM-CSF, but we ob-
served a high percentage of cells producing TNF-α, especially hHSC and
monocytes. Furthermore, the augmented frequency of L. infantum
phagocytosis was still observed in monocytes. Thereby, these data
suggest that the production of TNF-α by infected cells could be closely
related to increased hematopoiesis.
An increase of myelopoiesis in cultures of L. donovani infected cells
has previously been reported [7]. The greater number of CFU-GM re-
inforced this increase after cell culture in the presence of the parasite. In
contrast, another interesting ﬁnding of our study was the greater
number of red colonies in cultures with L. infantum infected cells after in
vitro hematopoiesis in addition to a greater percentage of CD235a+
cells. Our results are supported by the ﬁndings of Lafuse and colla-
borators (2013), who also observed increased frequency of BFU-E and
CFU-E after L. donovani infection in the gold hamster. It is known that
anemia is one of the main clinical ﬁndings during developmental of VL.
Low erythrocyte and erythrocyte precursor counts were also found in
studies with dogs infected with L. chagasi [19,26]. Thus, the increase in
the number of red colonies triggered by the presence of Leishmania
seems to be controversial, but this could be explained by a failure of red
blood cell diﬀerentiation. Steady-state levels of circulating erythrocytes
are maintained by erythropoiesis in the bone marrow [25]. Some stu-
dies reveal that analysis of bone marrow biopsies of VL patients indicate
cellular hyperplasia with many abnormal erythroblasts, which include
large erythroblasts containing giant lysosomes and nuclei with little
condensed chromatin and multinuclear erythroblasts with irregular
nuclei [13,30]. Furthermore, a decreased expression of erythroid dif-
ferentiation genes has been observed alpha-globin, beta-globin, and
ALAS2), which are target genes of GATA1 indicating a block in ery-
throblast diﬀerentiation [14]. So, despite the greater numbers of ery-
throid progenitors, failure of red blood cell diﬀerentiation may occur,
resulting in anemia in VL patients.
The evaluation of hematopoietic stem cell infection by Leishmania
and the consequences of the presence of the parasite in the functional
context of the bone marrow are extremely important to understanding
peculiar cases of VL in immunocompromised hosts. Additionally,
evaluating these aspects using human bone marrow samples is a rare
opportunity to better understand L. infantum infection dynamics, while
the vast majority of the studies are made only on non-human models.
Taking our data together, we can conclude that still undiﬀerentiated
bone marrow cells are able to phagocytize Leishmania and respond to
infection with the production of cytokines. In addition, macrophages
and granulocytes are also important phagocytes in the context of in-
fection, becoming activated and responding after parasite internaliza-
tion. Interestingly, the presence of L. infantum induces a diﬀerentiated
proﬁle of hematopoiesis, favoring the proliferation of cells of the ery-
throid lineage and altering the phenotypic proﬁles of their progeny.
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